Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Screen Shot 2015-07-29 at 11.09.41

EU announces investment in new treatments for Parkinson’s

Parkinson’s will be one of the main health areas to benefit from funding under the European Investment Bank’s (EIB) latest investment round.

The EIB – the EU’s long-term lending institution – has approved €10 billion of loans for a variety of strategic projects around the world.

These include medical research into Parkinson’s and epilepsy, as well as a host of infrastructure projects and investment in corporate research in the energy, automobile, and textile sectors.

Details of the investment in Parkinson’s have yet to be announced, but previously the EIB has provided funds for the development of new treatments by the Portuguese pharmaceutical company Bial.

In 2010-13 the EIB committed €50 million in loans to Bial’s research and development activities on drugs for epilepsy, cardiovascular affections and Parkinson’s disease.

Go Back

Share this story

Comments


Related articles


unite-for-parkinsons

Global update

EPDA and Parkinson’s UK launch #UniteForParkinsons campaign

Parkinson’s organisations around the world set to unite on World Parkinso

READ MORE
Kinetics film

Europe

‘Kinetics’: from the stage to the big screen

The Parkinson’s play has been turned into a feature film

READ MORE
Michael J Fox

Perspectives

Michael J Fox: “Now is our chance to honour Ali by finishing the fight he could not”

Remembering Muhammad Ali, two months after his death

READ MORE